Tag Archives: Waichman

C.R. Bards Transvaginal Mesh Devices Allegedly Utilize Plastic not Appropriate for Human Implantation, Notes Parker Waichman LLP

Posted on by


New York, New York (PRWEB) June 26, 2013

Parker Waichman LLP, a national law firm devoted to guarding the rights of victims injured by defective health-related devices, is reporting that C.R. Bard Inc., the subject of one of 5 transvaginal mesh-associated multidistrict litigations (MDL) consolidated in West Virginia, is alleged to have employed a resin-primarily based plastic said to be unsuitable for human implantation in its mesh devices, according to court records. A June 26 Bloomberg report noted that this info will be utilized in the upcoming July eight trial in the U.S. District Court for the Southern District of West Virginia, Charleston Division (Cisson v. C.R. Bard Inc., Case No. two:11-cv-00195), exactly where it is 1 of numerous instances pending in the MDL named In Re: C.R. Bard, Inc., Pelvic Repair Method Products Liability Litigation (MDL No 2187).

&#13

Bard managers employed a resin-primarily based plastic made by a unit of Chevron Phillips Chemical Co. to make healthcare mesh devices even soon after the supplier of the material warned that the plastic need to not be permanently implanted inside folks, according to emails and documents in the lawsuit more than Bards mesh implants. Lawyers for the thousands of females who filed lawsuits as component of the MDL against C.R. Bard, faulting its Avaulta line of transvaginal implants for their injuries, mentioned that court files show that not only did business officials know that the resin-based plastic utilised in the mesh wasnt fit for human implantation they also attempted to cover up their use of it, according to the Bloomberg report.

&#13

According to Bloomberg, U.S. District Judge Goodwin ruled that the e mail correspondence relating to the resin-based mesh raised a genuine concern of material fact about whether Bard was conscious its conduct was practically specific to trigger injuries. Goodwin will oversee 20,000 lawsuits now pending in U.S. District Court for the Southern District of West Virginia. Aside from C.R. Bard, the other MDLs are: In Re: Boston Scientific Products Liability Litigation, MDL No. 2326 In Re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2327 In Re Coloplast Corp. Pelvic Assistance Systems Goods Liability Litigation, MDL No. 2387 and In Re: American Healthcare Systems, Inc., Pelvic Repair System Goods Liability Litigation (MDL No. 2325).

&#13

When again we are faced with the possibility that a firm is a lot more concerned with the bottom line than the overall health and wellness of the individuals getting implanted with their merchandise, said Gary P. Falkowitz, a Managing Lawyer at Parker Waichman LLP. Businesses that make health-related devices ought to be extra vigilant about the supplies they use.

&#13

According to the U.S. Food and Drug Administration (FDA), transvaginal mesh devices had been authorized to treat tension urinary incontinence (SUI) and pelvic organ prolapse (POP), circumstances most typically triggered by weakened pelvic muscles. Transvaginal mesh devices are supposed to support right these circumstances by offering added strength to the pelvic walls. The FDA also reports that the most typical complications associated with transvaginal mesh may contain:

Supreme Court of New Jersey Appoints Parker Waichman LLPs Raymond C. Silverman Co-Lead Counsel in Mirena IUD Litigation

Posted on by


New York, New York (PRWEB) July 02, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective healthcare devices and drugs, is proud to announce that Partner Raymond C. Silverman has been appointed Co-Lead Counsel in the Mirena IUD multicounty litigation (MCL) entitled In Re: Mirena Litigation (Case No. 297 Master Docket No. BER-L-4098-13). The Order announcing this was filed on July 1, 2013.

&#13

Previously, Parker Waichmans Matthew J. McCauley, Senior Litigation Counsel, was appointed Co-Lead Counsel in the Mirena IUD multidistrict litigation (MDL) now taking place in the U.S. District Court for the Southern District of New York, which is entitled In Re: Mirena IUD Items Liability Litigation (Case No. 7:13-md-02434-CS). (Mr. McCauley also co-chairs the American Association for Justice (AAJ) Mirena IUD Litigation Group. The Group exchanges educational material and medical literature to aid the members greatest represent victims.)

&#13

On Could 29, 2013, the Supreme Court of New Jersey reversed an earlier decision and centralized Mirena IUD lawsuits in Bergen County, exactly where Superior Court Judge Brian R. Martinotti is managing them, according to a Notice to the Bar dated May 24, 2013.

&#13

On March six, 2013, Parker Waichman LLP had submitted an application asking the Superior Court of New Jersey to reconsider its preceding selection denying Bayers application for centralized management of multicounty litigation for Mirena IUD lawsuits. The application was entitled In Re: Application Pursuant to R. four:38A (Centralized Management of Multicounty Litigation) Joint Request for Reconsideration of Designation of Mirena litigation as a Multicounty Litigation for Centralized Management.

&#13

The application asked the court to reconsider centralizing due to the truth that more than 60 lawsuits alleging injuries from the Mirena IUD are involved in the litigation, with more lawsuits expected to be filed in the future. Parker Waichman LLP alone has filed much more than 50 cases in Morris County.

&#13

The U.S. Food and Drug Administration (FDA) authorized Bayers Mirena IUD was approved in 2000. The item is a little, t-shaped plastic device attached to two strings a hormonal IUD, it releases levonorgestrel when placed in the uterus to prevent pregnancy. Mirena is inserted and removed by a healthcare professional. It can be left in the uterus for up to five years. According to the FDA, the most serious side effects associated with the Mirena IUD contain: &#13

&#13

Transvaginal Mesh Merchandise Brought on Extreme Injuries in Texas Lady, Alleges Lawsuit Filed by Parker Waichman LLP

Posted on by


New York, New York (PRWEB) July 01, 2013

Parker Waichman LLP, a national law firm devoted to safeguarding the rights of victims injured by dangerous drugs and medical devices, has filed a lawsuit on behalf of a Texas woman who alleges that she was injured by transvaginal mesh items. The suit was filed on June ten, 2013, in the U.S. District Court for the Southern District of West Virginia (Case No. 2:13-cv-11164) in the multidistrict litigation (MDL) entitled In Re: Coloplast Corp., Pelvic Support System Merchandise Liability Litigation (MDL No. 2387). Mentor Worldwide LLC, Coloplast Corp., Ethicon, Inc., Ethicon, LLC, Johnson &amp Johnson and C.R. Bard, Inc. have been named as Defendants.

&#13

According to the Complaint, the Plaintiff was implanted with the Novasilk-Synthetic Flat Mesh in May 2011, the Alyte Y-Mesh in October 2012 and the TVT Exact in October 2012. These devices have been implanted to treat the Plaintiffs pelvic organ prolapse (POP) and stress urinary incontinence (SUI). The lawsuit alleges that these devices are defective and brought on critical and possibly permanent injuries. Moreover, the Defendants allegedly knew about these defects but did not warn consumers in order to protect their own financial interests. The Plaintiff is suing for discomfort and suffering, emotional distress, and economic loss, and is seeking compensation for punitive damages.

&#13

The U.S. Food and Drug Administration (FDA) reports that the most typical complications connected with transvaginal mesh may possibly include:

Diabetes Drug Actos Caused Bladder Cancer and Wrongful Death of Oklahoma Man, Alleges Lawsuit Filed by Parker Waichman LLP

Posted on by


New York, New York (PRWEB) June 25, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit on behalf of an Oklahoma man who developed bladder cancer and subsequently died, allegedly after taking the diabetes drug Actos (pioglitazone). The suit was filed on Might 23, 2013, in the U.S. District Court for the Western District of Louisiana (Case No. 6:13-cv-1237). It is one of thousands of circumstances that have been filed as component of the multidistrict litigation (MDL) entitled In Re: Actos (pioglitazone) Products Liability Litigation (six:11-md-2299). Takeda Pharmaceuticals, America Takeda Pharmaceuticals USA, Inc. f/k/a Takeda Pharmaceuticals North America, Inc. Takeda Pharmaceutical Firm Limited and Eli Lilly and Company have been named as Defendants. Jerrold S. Parker, founding partner of Parker Waichman LLP, serves on the Plaintiffs Steering Committee in the litigation.

&#13

According to the Complaint, the Plaintiff began taking Actos to treat his Variety 2 diabetes in November 2008. In January 2010, he was diagnosed with bladder cancer. He died in October 2012, allegedly due to the fact of Actos side effects. The lawsuit filed on his behalf alleges that the Defendants knew about the threat of bladder cancer but did not disclose this details to customers in order to protect economic interests. The Plaintiff alleges that Actos triggered pain and suffering, emotional distress and substantially decreased the Plaintiffs capability to take pleasure in life. The suit is also seeking damages for loss of consortium on behalf of the Plaintiffs spouse.

&#13

On June 15, 2011, the U.S. Meals and Drug Administration (FDA) warned that taking Actos for far more than a year could considerably increase the risk of bladder cancer. The safety label on Actos was updated to address this threat.

&#13

Some analysis research assistance the notion of a hyperlink amongst Actos and bladder cancer. The British Medical Journal published a study on Might 31, 2012, that revealed Actos customers were twice as probably to create bladder cancer right after two years. Then, on July three, 2012, the Canadian Health-related Association Journal reported that sufferers taking the medication have been 22 % much more likely to get bladder cancer.

&#13

Parker Waichman LLP continues to offer cost-free legal consultations to victims of Actos injuries, including bladder cancer, heart problems, and eye injuries. If you or a loved a single have been diagnosed with bladder cancer after taking Actos, please contact their workplace by going to yourlawyer.com. Free of charge case evaluations are also accessible by calling 1-800-LAW-Info (1-800-529-4636).

&#13

Get in touch with: &#13

Parker Waichman LLP &#13

Gary Falkowitz, Managing Lawyer &#13

(800) LAW-Info &#13

(800) 529-4636 &#13

http://www.yourlawyer.com

&#13
&#13
&#13
&#13
&#13

Parker Waichman LLP Represents Pennsylvania Man in Lawsuit Alleging Actos Triggered his Bladder Cancer

Posted on by


New York, New York (PRWEB) June 07, 2013

Parker Waichman LLP, a national law firm dedicated to defending the victims of defective drugs, has filed a lawsuit on behalf of a Pennsylvania man who allegedly created bladder cancer soon after taking the diabetes drug Actos (pioglitazone). The suit was filed on May 23rd in the U.S. District Court for the Western District of Louisiana (Case No. 6:13-cv-1170) as part of the multidistrict litigation entitled In Re: Actos (Pioglitazone) Items Liability Litigation (six:11-md-2299). Takeda Pharmaceuticals, America Takeda Pharmaceuticals USA, Inc. f/k/a Takeda Pharmaceuticals North America, Inc. Takeda Pharmaceutical Company Limited and Eli Lilly and Business have been named as Defendants.

&#13

According to the Complaint, the Plaintiff started taking Actos in November 2003 to treat his Kind two diabetes. By August 2006, he was diagnosed with bladder cancer. The suit alleges that Actos brought on the bladder cancer due to its defective nature. In addition, the suit alleges that the Defendants knew about the risk of bladder cancer but failed to disclose this data to shoppers in order to safeguard financial interests. The Plaintiff is alleging that Actos brought on discomfort and suffering, emotional distress and economic damages in the type of healthcare costs and lost wages. The suit is also in search of damages for loss of consortium on behalf of the Plaintiffs spouse.

&#13

In June 2011, the U.S. Food and Drug Administration (FDA) warned that taking Actos for more than a year could significantly boost the risk of bladder cancer. The security label on Actos was updated to address this danger*. Further analysis supports the link between Actos and bladder cancer. Final May possibly, a study in the British Health-related Journal** identified that Actos users were twice as likely to create bladder cancer right after two years. That July, the Canadian Healthcare Association Journal*** discovered that sufferers taking the medication had been 22 % far more probably to get bladder cancer. &#13

*http://www.fda.gov/Drugs/DrugSafety/ucm266555.htm&#13

**(http://www.bmj.com/content material/344/bmj.e3645) &#13

***(http://www.cmaj.ca/content material/early/2012/07/03/cmaj.112102)

&#13

Parker Waichman LLP continues to offer you free of charge legal consultations to victims of Actos injuries, which includes bladder cancer, heart troubles, and eye injuries. If you or a loved 1 had been diagnosed with bladder cancer following taking Actos, please contact their office by visiting yourlawyer.com. Totally free case evaluations are also available by calling 1 800 LAW Information (1-800-529-4636).

&#13

Make contact with: &#13

Parker Waichman LLP &#13

Gary Falkowitz, Managing Attorney &#13

(800) LAW-Information &#13

(800) 529-4636 &#13

http://www.yourlawyer.com

&#13
&#13
&#13
&#13
&#13

Woman with Bilateral DePuy Pinnacle Hip Implant Alleges Metal Hips are Flawed in Lawsuit Filed by Parker Waichman LLP

Posted on by


New York, New York (PRWEB) June 05, 2013

Parker Waichman LLP, a national law firm dedicated to guarding the rights of victims injured by defective medical devices, has filed a lawsuit on behalf of a lady implanted with two DePuy Pinnacle hips. The lawsuit was filed on March 25th in the U.S. District Court for the Northern District of Texas (Case No. 3:13-cv-01247-K) as portion of the DePuy Pinnacle multidistrict litigation (MDL No. three:11-md-02244). DePuy Orthopaedics, Inc. and Johnson &amp Johnson are the Defendants.

&#13

According to the Complaint, the Plaintiff was implanted with a Pinnacle hip on her left side in January 2007, and then had another Pinnacle hip implanted on her correct side in December 2008. The lawsuit alleges that the implants caused complications, which includes extreme pain, weakness and elevated chromium and cobalt levels in the womans bloodstream. The symptoms have been stated to have grown so severe that she needed to undergo a revision surgery to correct the troubles. Allegedly, the Defendants had been conscious of the potential for these dangers but failed to disclose them to the Plaintiff, her doctor or the public. The Plaintiff is suing for, amongst other factors, pain and suffering, emotional distress and financial loss due to lost wages and healthcare costs.

&#13

The lawsuit alleges that the Pinnacle is flawed simply because the metal-on-metal design causes the shedding of chromium and cobalt particles, which are then released into the physique. On January 17 of this year, the U.S. Meals and Drug Administration (FDA) issued a Security Alert that acknowledged these dangers, issuing new suggestions for all-metal hip individuals. The agency advised that those with implants undergo physical exams, diagnostics imaging and metal-ion testing when necessary. In that very same alert, the FDA also proposed new, stricter suggestions that would call for makers to prove that their devices are safe and successful by means of clinical testing this strategy is referred to as premarket approval. The existing approval route, recognized as the 510(k), only calls for device makers to show that their product is comparable to a previously approved device already on the marketplace.

&#13

Parker Waichman LLP continues to offer you totally free legal consultations to victims of DePuy Pinnacle and other metal-on-metal hip implant injuries. If you or a loved a single have seasoned premature failure of your implant, or other overall health troubles related with the Pinnacle or other metal-on-metal hip replacement device, please get in touch with their office by visiting the firm’s DePuy Pinnacle hip implant lawsuits web page at yourlawyer.com. Cost-free case evaluations are also available by calling 1 800 LAW Information (1-800-529-4636).

&#13

Get in touch with: &#13

Parker Waichman LLP &#13

Gary Falkowitz, Managing Lawyer &#13

(800) LAW-Information &#13

(800) 529-4636 &#13

http://www.yourlawyer.com

&#13
&#13
&#13
&#13
&#13

Find A lot more Administrator Press Releases